AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
11
5
previous day
The U.S. is a key market for the pharmaceutical industry. AstraZeneca expects 50 percent of its revenue to come from the U.S. by 2030.
© Fortune
visit website